Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male.
Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male.
复制标题
DOI:
10.1016/j.cmet.2016.03.015
复制
发表时间:
2016-05-10
期刊:
影响因子:
29
通讯作者:
Mauvais-Jarvis F
中科院分区:
文献类型:
--
作者:
Navarro G;Xu W;Jacobson DA;Wicksteed B;Allard C;Zhang G;De Gendt K;Kim SH;Wu H;Zhang H;Verhoeven G;Katzenellenbogen JA;Mauvais-Jarvis F
Although men with testosterone deficiency are at increased risk of type 2 diabetes (T2D), previous studies have ignored the role of testosterone and the androgen receptor (AR) in pancreatic β–cells. We show that male mice lacking AR in β-cells (βARKO) exhibit decreased glucose-stimulated insulin secretion (GSIS) leading to glucose intolerance. The AR agonist dihydrotestosterone (DHT) enhances GSIS in cultured male islets, an effect that is abolished in βARKO−/y islets and human islets treated with an AR antagonist. In β-cells, DHT-activated AR is predominantly extranuclear and enhances GSIS by increasing islet cAMP and activating the protein kinase A. In mouse and human islets, the insulinotropic effect of DHT depends on activation of the glucagon like peptide-1 (GLP-1) receptor and accordingly, DHT amplifies the incretin effect of GLP-1. This study identifies AR as a novel receptor that enhances β-cell function, a finding with implications for prevention of T2D in aging men.